Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 35 (10) 1061-1069
Year:
2017
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
6
Parents:
657   784   2171  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821 and U10CA180882 (to the Alliance for Clinical Trials in Oncology), U10CA180857, U10CA180858, U10CA180870, U10CA180833, CA31946 , CA33601, CA105409, U10CA031983, U10CA037347, U10CA047577, U10CA077440, R01-CA095614, U24-CA114736, U10-CA076001, U01-CA114722 , U10 CA047577, U10 CA031946, U10 CA033601, U10 CA180821, U10 CA180858, U01 CA114722, U10 CA077440, U10 CA180857, U10 CA105409, P30 CA091842, U10 CA180882, U24 CA196171, U10 CA076001, U10 CA180833, U10 CA180870, U10 CA180838, U24 CA114736, R01 CA095614  
Corr. Author:
 
Authors:
                                                               
Networks:
CA136, ESSENTIA, GA005, KY015, LAPS-CT018, LAPS-MO011, LAPS-NC007, LAPS-TX011, LAPS-TX035, NEWMEXICO, OH029, TN118, TX041, TX190   
Study
ACOSOG-Z1031B
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Chemotherapy, Combined Modality, Hormonal Therapy, Translational Oncology, ORIGINAL REPORTS, Breast Cancer